The Medovate SAFIRA has received an Innovative Technology contract from Vizient, Inc. the US’s largest member-driven health care performance improvement company.
The contract has been awarded following the recommendation of SAFIRA by hospital experts who serve on one of Vizient’s member-led hospital and healthcare councils.
The product was submitted through Vizient’s “Innovative Technology Program” which creates visibility to innovative products and services.
Vizient members identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety or improve business operations of healthcare organisations.
Stuart Thomson, Managing Director, at Medovate said: “We are excited to announce that our SAFIRA system is now available through one of the largest national GPO programmes in the USA.
“This is really positive news for Medovate as it helps streamline the purchase of SAFIRA for healthcare organisations delivering services and treatments which use regional anesthesia, such as ambulatory care and surgical centres.
“It is a great opportunity to increase the availability of our game-changing technology to regional anaesthesia practitioners in the USA to help improve patient safety during peripheral nerve blocks.”
The current regional anaesthesia procedure typically requires an assistant to inject the anaesthetic while the anaesthetist uses ultrasound guidance to place the needle.
SAFIRA is a novel technology, developed alongside specialist anaesthesia clinicians in the NHS, designed to reduce the risk of nerve injury during regional anaesthesia.
The SAFIRA system automatically limits injection pressure to a specified threshold to help reduce the risk of nerve injury and improve patient safety.
It also transforms regional anaesthesia into a one-person procedure by enabling anaesthetists to conduct the entire nerve block process.
Kelly Flaharty, senior director of contract services for Vizient, said:
“Congratulations to Medovate for being awarded an Innovative Technology contract.
“Our member council recommended SAFIRA for this contract based on the efficiencies it offers and its potential to make an incremental difference in healthcare.”